Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Fungizone® (Amphotericin B for injection) - Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
28/05/2009
Problem Or Issue:
Important safety information communication from Bristol-Myers Squibb Pharmaceuticals on the risk of overdose due to confusion between Lipid- and Non-lipid-based Formulations of Parenteral Amphotericin B, including Fungizone® (Amphotericin B for injection)
Fungizone® (Amphotericin B for injection) - Important Safety Information
« Back
Date Printed: 13/05/2024